BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37005753)

  • 1. Astragaloside IV Inhibits NLRP3 Inflammasome-Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction.
    Chen X; Tian C; Zhang Z; Qin Y; Meng R; Dai X; Zhong Y; Wei X; Zhang J; Shen C
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):45. PubMed ID: 37005753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
    Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
    Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.
    Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT
    Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.
    Hwang S; Kim SH; Yoo KH; Chung MH; Lee JW; Son KH
    BMC Mol Cell Biol; 2022 Dec; 23(1):55. PubMed ID: 36517746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV Alleviates Doxorubicin-Induced Cardiotoxicity by Inhibiting Cardiomyocyte Pyroptosis through the SIRT1/NLRP3 Pathway.
    Tian W; Zhang P; Yang L; Song P; Zhao J; Wang H; Zhao Y; Cao L
    Am J Chin Med; 2024; 52(2):453-469. PubMed ID: 38490806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation.
    Zhang L; Fan C; Jiao HC; Zhang Q; Jiang YH; Cui J; Liu Y; Jiang YH; Zhang J; Yang MQ; Li Y; Xue YT
    Oxid Med Cell Longev; 2022; 2022():1733834. PubMed ID: 35035656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation.
    Wang Y; Liao J; Luo Y; Li M; Su X; Yu B; Teng J; Wang H; Lv X
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifuroxazide mitigates doxorubicin-induced cardiovascular injury: Insight into oxidative/NLRP3/GSDMD-mediated pyroptotic signaling modulation.
    Amin FM; Sharawy MH; Amin MN; El-Sherbiny M; Said E; Salem HA; Ibrahim TM
    Life Sci; 2023 Feb; 314():121311. PubMed ID: 36549350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
    Tavakoli Dargani Z; Singla DK
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway.
    Jin X; Fu W; Zhou J; Shuai N; Yang Y; Wang B
    Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
    Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
    Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
    Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
    Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyl fumarate ameliorates erectile dysfunction in bilateral cavernous nerve injury rats by inhibiting oxidative stress and NLRP3 inflammasome-mediated pyroptosis of nerve via activation of Nrf2/HO-1 signaling pathway.
    Song G; Wang J; Liu J; Ruan Y
    Redox Biol; 2023 Dec; 68():102938. PubMed ID: 37931471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irisin protects against cardiac injury by inhibiting NLRP3 inflammasome-mediated pyroptosis during remodeling after infarction.
    Jin L; Piao Z
    Int Immunopharmacol; 2024 Mar; 130():111714. PubMed ID: 38412677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner.
    Yu W; Qin X; Zhang Y; Qiu P; Wang L; Zha W; Ren J
    Cardiovasc Diagn Ther; 2020 Aug; 10(4):752-769. PubMed ID: 32968631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia-Reoxygenation.
    Yang P; Zhou Y; Xia Q; Yao L; Chang X
    Biol Pharm Bull; 2019 May; 42(5):721-727. PubMed ID: 30867343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity.
    Waz S; Matouk AI
    Toxicol Mech Methods; 2022 Mar; 32(3):194-203. PubMed ID: 34635025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eldecalcitol Inhibits LPS-Induced NLRP3 Inflammasome-Dependent Pyroptosis in Human Gingival Fibroblasts by Activating the Nrf2/HO-1 Signaling Pathway.
    Huang C; Zhang C; Yang P; Chao R; Yue Z; Li C; Guo J; Li M
    Drug Des Devel Ther; 2020; 14():4901-4913. PubMed ID: 33223823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation.
    Cao R; Fang D; Wang J; Yu Y; Ye H; Kang P; Li Z; Wang H; Gao Q
    J Diabetes Res; 2019; 2019():4857921. PubMed ID: 31871948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hesperetin ameliorates spinal cord injury by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling.
    Liu Z; Tu K; Zou P; Liao C; Ding R; Huang Z; Huang Z; Yao X; Chen J; Zhang Z
    Int Immunopharmacol; 2023 May; 118():110103. PubMed ID: 37001385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.